HUTCHMED (China) Limited (HK:0013) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
HUTCHMED (China) Limited has appointed Dr. Chaohong Hu as an Independent Non-executive Director and a member of its Technical Committee, effective November 21, 2024. Dr. Hu brings over 20 years of experience in biopharmaceuticals, including leadership roles in therapeutic antibody development and strategic partnerships. This appointment is expected to infuse fresh insights into the company’s board, enhancing its strategic direction in the biopharmaceutical industry.
For further insights into HK:0013 stock, check out TipRanks’ Stock Analysis page.
